Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Mellitus: An Umbrella Review of Systematic Reviews.
Saved in:
| Title: | Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Mellitus: An Umbrella Review of Systematic Reviews. |
|---|---|
| Authors: | Shabil M; Department of Pharmacy Practice, Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bangalore, India., Kasoj M; Kalam Institute of Health Technology, Visakhapatnam, India., Sulthana H; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, MS Ramaiah University of Applied Sciences, Bangalore, India., Ullah A; Department of Pharmacy, University of Peshawar, Peshawar, KPK, Pakistan.; Department of Pharmacy, Hazara University, Mansehra, KPK, Pakistan., Verma A; Department of Internal Medicine, Rama Medical College Hospital and Research Centre, Hapur, Uttar Pradesh, 245304, India., Sah R; Department of Paediatrics, Dr. D. Y. Patil Medical College Hospital and Research Centre, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pimpri, Pune, Maharashtra, 411018, India.; Department of Public Health Dentistry, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth (Deemed-to-be-University), Pune, Maharashtra, 411018, India., Mehta R; Clinical Microbiology, RDC, Manav Rachna International Institute of Research and Studies, Faridabad, Haryana, 121004, India., Babaresh WM; Faculty of Pharmacy, University of Aden, Aden, Yemen. |
| Source: | Diabetes, metabolic syndrome and obesity : targets and therapy [Diabetes Metab Syndr Obes] 2025 Dec 02; Vol. 18, pp. 4423-4437. Date of Electronic Publication: 2025 Dec 02 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Dove Medical Press Country of Publication: New Zealand NLM ID: 101515585 Publication Model: eCollection Cited Medium: Print ISSN: 1178-7007 (Print) Linking ISSN: 11787007 NLM ISO Abbreviation: Diabetes Metab Syndr Obes Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
